Aging, Immunity, and the Varicella–Zoster Virus
Top Cited Papers
- 2 June 2005
- journal article
- editorial
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 352 (22) , 2266-2267
- https://doi.org/10.1056/nejmp058091
Abstract
Older people and their physicians are all too well acquainted with herpes zoster — commonly called shingles, from the Latin cingulum, or “girdle.” Most recognize that aging creates a special vulnerability to this often severely painful skin rash caused by varicella–zoster virus (VZV). VZV is so named because varicella (chickenpox) represents the first encounter between the virus and the host, and herpes zoster represents the second. VZV persists in the sensory ganglia of the cranial nerves and the spinal dorsal-root ganglia after varicella resolves, and it may become reactivated after many decades of latency; molecular analyses of VZV DNA demonstrate . . .Keywords
This publication has 3 references indexed in Scilit:
- A Vaccine to Prevent Herpes Zoster and Postherpetic Neuralgia in Older AdultsNew England Journal of Medicine, 2005
- Use of an Inactivated Varicella Vaccine in Recipients of Hematopoietic-Cell TransplantsNew England Journal of Medicine, 2002
- Neurologic Complications of the Reactivation of Varicella–Zoster VirusNew England Journal of Medicine, 2000